A detailed history of Ronald Blue Trust, Inc. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 17,409 shares of MRVI stock, worth $101,146. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,409
Previous 6,194 181.06%
Holding current value
$101,146
Previous $44,000 227.27%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$6.84 - $9.73 $76,710 - $109,121
11,215 Added 181.06%
17,409 $144,000
Q2 2024

Jul 18, 2024

BUY
$6.87 - $11.34 $42,552 - $70,239
6,194 New
6,194 $44,000
Q4 2023

Jan 18, 2024

BUY
$4.7 - $9.87 $2,570 - $5,398
547 New
547 $5,000
Q1 2023

Apr 17, 2023

SELL
$12.99 - $16.48 $519 - $659
-40 Reduced 72.73%
15 $0
Q4 2022

Jan 17, 2023

BUY
$12.5 - $24.78 $687 - $1,362
55 New
55 $1,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $764M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.